- Home
- GROY vs ABEO Comparison
GROY vs ABEO Comparison
Compare GROY & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- ABEO
- Stock Information
- Founded
- GROY 2020
- ABEO 1974
- Country
- GROY Canada
- ABEO United States
- Employees
- GROY 16
- ABEO N/A
- Industry
- GROY
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- GROY
- ABEO Health Care
- Exchange
- GROY Nasdaq
- ABEO Nasdaq
- Market Cap
- GROY 618.0M
- ABEO 332.0M
- IPO Year
- GROY 2021
- ABEO 1980
- Fundamental
- Price
- GROY $3.62
- ABEO $6.83
- Analyst Decision
- GROY Strong Buy
- ABEO Strong Buy
- Analyst Count
- GROY 4
- ABEO 6
- Target Price
- GROY $4.58
- ABEO $18.17
- AVG Volume (30 Days)
- GROY 2.5M
- ABEO 702.3K
- Earning Date
- GROY 08-06-2025
- ABEO 08-14-2025
- Dividend Yield
- GROY N/A
- ABEO N/A
- EPS Growth
- GROY N/A
- ABEO N/A
- EPS
- GROY N/A
- ABEO 0.99
- Revenue
- GROY $12,376,000.00
- ABEO $400,000.00
- Revenue This Year
- GROY $82.74
- ABEO N/A
- Revenue Next Year
- GROY $51.73
- ABEO $339.63
- P/E Ratio
- GROY N/A
- ABEO $6.91
- Revenue Growth
- GROY 90.37
- ABEO N/A
- 52 Week Low
- GROY $1.16
- ABEO $3.93
- 52 Week High
- GROY $3.65
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- GROY 65.91
- ABEO 52.71
- Support Level
- GROY $2.89
- ABEO $6.70
- Resistance Level
- GROY $3.37
- ABEO $7.15
- Average True Range (ATR)
- GROY 0.15
- ABEO 0.31
- MACD
- GROY 0.01
- ABEO -0.02
- Stochastic Oscillator
- GROY 85.59
- ABEO 46.62
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.